Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Celularity Inc WT (CELUW)

Celularity Inc WT (CELUW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Celularity and Fountain Life Announce Availability of Cenplacel-L for Investigational Use Under New Florida Law, Establishing Scalable Pathway for Advancement of Placental-Derived Cell Therapies GlobeNewswire - Thu Jun 4, 7:00AM CDT

FLORHAM PARK, N.J. and ORLANDO, Fla., June 04, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a longevity-focused regenerative and cellular medicine company pioneering placental-derived...

CELU : 0.7129 (-1.91%)
CELUW : 0.0057 (unch)
Celularity Releases CEO Letter to Shareholders GlobeNewswire - Wed Jun 3, 3:15PM CDT

FLORHAM PARK, N.J., June 03, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) ("Celularity" or the "Company"), a longevity-focused regenerative and cellular medicine company pioneering placental-derived...

CELU : 0.7129 (-1.91%)
CELUW : 0.0057 (unch)
Celularity Appoints Rick Gonzalez as Chief Commercial Officer GlobeNewswire - Wed Jun 3, 7:00AM CDT

FLORHAM PARK, N.J., June 03, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a longevity-focused regenerative and cellular medicine company pioneering...

CELU : 0.7129 (-1.91%)
CELUW : 0.0057 (unch)
Celularity Receives Nasdaq Notice Regarding Form 10-Q GlobeNewswire - Fri May 29, 4:15PM CDT

FLORHAM PARK, N.J., May 29, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (the “Company”), a longevity-focused regenerative and cellular medicine company, today announced that it received...

CELU : 0.7129 (-1.91%)
CELUW : 0.0057 (unch)
Celularity Announces Filing of Form 10-K, Regains Nasdaq Compliance and Highlights Continued Strategic Transformation GlobeNewswire - Fri May 1, 3:30PM CDT

FLORHAM PARK, N.J., May 01, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a longevity-focused regenerative and cellular medicine company, today announced...

CELU : 0.7129 (-1.91%)
CELUW : 0.0057 (unch)
Celularity Announces Closing of Transaction with NexGel GlobeNewswire - Tue Apr 21, 7:30AM CDT

FLORHAM PARK, N.J., April 21, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a longevity-focused regenerative and cellular medicine company, today announced the closing of...

CELU : 0.7129 (-1.91%)
CELUW : 0.0057 (unch)
Celularity Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing GlobeNewswire - Fri Apr 17, 3:35PM CDT

FLORHAM PARK, N.J., April 17, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (the “Company”), a longevity-focused regenerative and cellular medicine company, today announced that on April...

CELU : 0.7129 (-1.91%)
CELUW : 0.0057 (unch)
Celularity Reiterates Strategic Commercialization Partnership with NEXGEL Focused on Building Biomaterials Franchise with Established Commercial Products and New 510(k) Pathway Product Opportunities GlobeNewswire - Thu Mar 12, 7:30AM CDT

Biovance, Biovance 3L, Natalin, Acelagraft, Interfyl and Centaflex licensed to NEXGEL are established commercial products widely used today in wound care, orthopedics and other indications. Three pipeline...

CELU : 0.7129 (-1.91%)
NXGL : 0.5510 (-6.61%)
CELUW : 0.0057 (unch)
Celularity Secures $35 Million Strategic License Deal, Strengthens Capital Position to Advance Longevity-Focused Strategy GlobeNewswire - Tue Mar 10, 7:30AM CDT

Transaction expected to generate up to $35 million in upfront and milestone payments Celularity retains exclusive manufacturing rights, creating continued biomaterials revenue and margin opportunity ...

CELU : 0.7129 (-1.91%)
CELUW : 0.0057 (unch)
Celularity Receives $12.2 Million from Sale of New Jersey Net Operating Losses GlobeNewswire - Tue Feb 10, 7:30AM CST

FLORHAM PARK, N.J., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a longevity-focused regenerative and cellular medicine company, today announced receipt of $12.2...

CELU : 0.7129 (-1.91%)
CELUW : 0.0057 (unch)

Barchart Exclusives

Mark Cuban Says Everything in the Hospital Could Cost $1 And Insurance Companies Would Still Raise the Prices to ‘Crush People’s Financial Situation’ Barchart - 1 hour ago
Billionaire Mark Cuban argued that even if hospital services cost just $1, large insurance conglomerates would still drive prices higher, highlighting opportunities for healthcare disruptors. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.